CEFZIDE INJ

CEFZIDE 1.125 INJ

Brand Name: CEFZIDE-1.125
Molecules: Ceftazidime & Tazobactam
Therapeutic Category: Antibiotic Combination (Cephalosporin & Beta-Lactamase Inhibitor)
Dosage Form: Powder for Injection
Strength: 1.125 gm (Ceftazidime 1 gm + Tazobactam 0.125 gm)
Route of Administration: Intravenous (I.V.) Use Only
Packaging: Not specified (typically available as a vial of powder for reconstitution)

Key Features:

Ceftazidime (1 gm): A third-generation cephalosporin antibiotic with potent activity against Gram-negative bacteria, including Pseudomonas aeruginosa.
Tazobactam (0.125 gm): A beta-lactamase inhibitor that enhances the effectiveness of Ceftazidime by preventing bacterial resistance.

Indications:

CEFZIDE-1.125 Injection are indicated for:

Treatment of severe bacterial infections (e.g., respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections)
Management of infections caused by beta-lactamase-producing bacteria
Hospital-acquired infections, including septicemia and infections in immunocompromised patients

Advantages:

Powerful combination of a cephalosporin and beta-lactamase inhibitor for enhanced efficacy.
Broad-spectrum coverage against a wide range of bacterial infections, including resistant strains.
Effective against Pseudomonas aeruginosa and other Gram-negative pathogens.

Precautions:

Use only under medical supervision. Complete the full course of treatment to prevent antibiotic resistance.
Not recommended for patients with a history of penicillin or cephalosporin allergy.
Use only under medical supervision. Complete the full course of treatment to prevent antibiotic resistance.

Packaging:

Typically available as a vial of powder for reconstitution.

Let’s Stay In Touch

Shopping cart

Antibiotics